Alterations in exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury

Journal of Applied Physiology

Volumn 115, Issue 10, 2013, Pages 1487-1495

  Bos, Lieuwe D J ^a   Van Walree, Inez C ^a   Kolk, Arend H J ^a   Janssen, Hans Gerd ^a   Sterk, Peter J ^a   Schultz, Marcus J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Exhaled breath; Lipopolysaccharide; Lung injury; Volatile organic compound

Indexed keywords

BIOLOGICAL MARKER; LIPOPOLYSACCHARIDE; VOLATILE ORGANIC COMPOUND;

ANIMAL; ARTICLE; BREATH ANALYSIS; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; EXHALATION; EXHALED BREATH; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS ADMINISTRATION; LUNG; LUNG INJURY; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; METABOLOMICS; METHODOLOGY; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TIME; VOLATILIZATION;

EXHALED BREATH; LIPOPOLYSACCHARIDE; LUNG INJURY; VOLATILE ORGANIC COMPOUND;

ADMINISTRATION, INHALATION; ADMINISTRATION, INTRAVENOUS; ANIMALS; BIOLOGICAL MARKERS; BREATH TESTS; DISEASE MODELS, ANIMAL; EXHALATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; LIPOPOLYSACCHARIDES; LUNG; LUNG INJURY; MALE; METABOLOMICS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VOLATILIZATION;

EID: 84888311547     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00685.2013     Document Type: Article

References (48)

1. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 19: 716-723, 1974.
2. Aksenov AA, Gojova A, Zhao W, Morgan JT, Sankaran S, Sandrock CE, Davis CE. Characterization of volatile organic compounds in human leukocyte antigen heterologous expression systems: A cell's "chemical odor fingerprint". Chembiochem 13: 1053-1059, 2012.
3. Aslami H, Kuipers MT, Beurskens CJ, Roelofs JJ, Schultz MJ, Juffermans NP. Mild hypothermia reduces ventilator-induced lung injury, irrespective of reducing respiratory rate. Transl Res 159: 110-117, 2011.
4. Barnett N, Ware LB. Biomarkers in acute lung injury-marking forward progress. Crit Care Clin 27: 661-683, 2011.
5. Bellani G, Messa C, Guerra L, Spagnolli E, Foti G, Patroniti N, Fumagalli R, Musch G, Fazio F, Pesenti A. Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study. Crit Care Med 37: 2216-2222, 2009.
6. Boots AW, van Berkel JJ, Dallinga JW, Smolinska A, Wouters EF, van Schooten FJ. The versatile use of exhaled volatile organic compounds in human health and disease. J Breath Res 6: 027108, 2012.
7. Boshier PR, Hanna GB, Marczin N. Exhaled nitric oxide as biomarker of acute lung injury: An unfulfilled promise? J Breath Res 7: 017118, 2013.
8. Caldeira M, Perestrelo R, Barros AS, Bilelo MJ, Morete A, Camara JS, Rocha SM. Allergic asthma exhaled breath metabolome: A challenge for comprehensive two-dimensional gas chromatography. J Chromatogr A 1254: 87-97, 2012.
9. Chang DW, Hayashi S, Gharib SA, Vaisar T, King ST, Tsuchiya M, Ruzinski JT, Park DR, Matute-Bello G, Wurfel MM, Bumgarner R, Heinecke JW, Martin TR. Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome. Am J Respir Crit Care Med 178: 701-709, 2008.
10. Chun H, Keles S. Sparse partial least squares regression for simultaneous dimension reduction and variable selection. J R Stat Soc Series B Stat Methodol 72: 3-25, 2010.
11. Cope KA, Watson MT, Foster WM, Sehnert SS, Risby TH. Effects of ventilation on the collection of exhaled breath in humans. J Appl Physiol 96: 1371-1379, 2004.
12. Corradi M, Rubinstein I, Andreoli R, Manini P, Caglieri A, Poli D, Alinovi R, Mutti A. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 1380-1386, 2003.
13. Esteban A, Anzueto A, Frutos F, Alía I, Brochard L, Stewart TE, Benito S, Epstein SK, Apezteguía C, Nightingale P, Arroliga AC, Tobin MJ; Mechanical Ventilation Study Group. Characteristics and outcomes in adult patients receiving mechanical ventilation: A 28-day international study. JAMA 287: 345-355, 2002.
14. Esteban A, Fernández-Segoviano P, Frutos-Vivar F, Aramburu JA, Nájera L, Ferguson ND, Alía I, Gordo F, Ríos F. Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings. Ann Intern Med 141: 440-445, 2004.
15. Fens N, de Nijs SB, Peters S, Dekker T, Knobel HH, Vink TJ, Willard NP, Zwinderman AH, Krouwels FH, Janssen HG, Lutter R, Sterk PJ. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Eur Respir J 38: 1301-1309, 2011.
16. Fens N, Zwinderman AH, van der Schee MP, de Nijs SB, Dijkers E, Roldaan AC, Cheung D, Bel EH, Sterk PJ. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 180: 1076-1082, 2009.
17. Fitts DA. Ethics and animal numbers: informal analyses, uncertain sample sizes, inefficient replications, and type I errors. J Am Assoc Lab Anim Sci 50: 445-453, 2011.
18. Fuchs P, Loeseken C, Schubert JK, Miekisch W. Breath gas aldehydes as biomarkers of lung cancer. Int J Cancer 126: 2663-2670, 2010.
19. Gajic O, Dabbagh O, Park PK, Adesanya A, Chang SY, Hou P, Anderson H 3rd, Hoth JJ, Mikkelsen ME, Gentile NT, Gong MN, Talmor D, Bajwa E, Watkins TR, Festic E, Yilmaz M, Iscimen R, Kaufman DA, Esper AM, Sadikot R, Douglas I, Sevransky J, Malin- choc M; U.S. Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG-LIPS). Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 183: 462-470, 2011.
20. Guamán AV, Carreras A, Calvo D, Agudo I, Navajas D, Pardo A, Marco S, Farré R. Rapid detection of sepsis in rats through volatile organic compounds in breath. J Chromatogr B Analyt Technol Biomed Life Sci 881-882: 76-82, 2012.
21. Ibrahim B, Basanta M, Cadden P, Singh D, Douce D, Woodcock A, Fowler SJ. Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax 66: 804-809, 2011.
22. Izquierdo-García JL, Nin N, Ruíz-Cabello J, Rojas Y, de Paula M, López-Cuenca S, Morales L, Martinez-Caro L, Fernández- Segoviano P, Esteban A, Lorente JA. A metabolomic approach for diagnosis of experimental sepsis. Intensive Care Med 37: 2023-2032, 2011.
23. King J, Koc H, Unterkofler K, Mochalski P, Kupferthaler A, Teschl G, Teschl S, Hinterhuber H, Amann A. Physiological modeling of isoprene dynamics in exhaled breath. J Theor Biol 267: 626-637, 2010.
24. Kischkel S, Miekisch W, Sawacki A, Straker EM, Trefz P, Amann A, Schubert JK. Breath biomarkers for lung cancer detection and assessment of smoking related effects- confounding variables, influence of normalization and statistical algorithms. Clin Chim Acta 411: 1637-1644, 2010.
25. Levitt JE, Gould MK, Ware LB, Matthay MA. The pathogenetic and prognostic value of biologic markers in acute lung injury. J Intensive Care Med 24: 151-167, 2009.
26. Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 33: 319-327, 2005.
27. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 44: 725-738, 2011.
28. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295: L379-L399, 2008.
29. Moser B, Bodrogi F, Eibl G, Lechner M, Rieder J, Lirk P. Mass spectrometric profile of exhaled breath-field study by PTR-MS. Respir- Physiol Neurobiol 145: 295-300, 2005.
30. Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature 455: 1054-1056, 2008.
31. O'Neill HJ, Gordon SM, Krotoszynski B, Kavin H, Szidon JP. Identification of isoprenoid-type components in human expired air: A possible shunt pathway in sterol metabolism. Biomed Chromatogr 2: 66-70, 1987.
32. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F 2nd, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 164: 1896-1903, 2001.
33. Patti GJ, Tautenhahn R, Siuzdak G. Meta-analysis of untargeted metabolomic data from multiple profiling experiments. Nat Protoc 7: 508-516, 2012.
34. Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci USA 68: 2374-2376, 1971.
35. Phua J, Stewart TE, Ferguson ND. Acute respiratory distress syndrome 40 years later: Time to revisit its definition. Crit Care Med 36: 2912-2921, 2008.
36. Pryor WA, Das B, Church DF. The ozonation of unsaturated fatty acids: Aldehydes and hydrogen peroxide as products and possible mediators of ozone toxicity. Chem Res Toxicol 4: 341-348, 1991.
37. R Core Team. R: A language and environment for statistical computing. Vienna, 2010.
38. Risby TH. Critical issues for breath analysis. J Breath Res 2: 030302, 2008.
39. Röck F, Barsan N, Weimar U. Electronic nose: current status and future trends. Chem Rev 108: 705-725, 2008.
40. Serkova NJ, Van Rheen Z, Tobias M, Pitzer JE, Wilkinson JE, Stringer KA. Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 295: L152-L161, 2008.
41. Shin HW, Umber BJ, Meinardi S, Leu SY, Zaldivar F, Blake DR, Cooper DM. Acetaldehyde and hexanaldehyde from cultured white cells. J Transl Med 7: 31, 2009.
42. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78: 779-787, 2006.
43. Stringer KA, Serkova NJ, Karnovsky A, Guire K, Paine R 3rd, Standiford TJ. Metabolic consequences of sepsis-induced acute lung injury revealed by plasma (1)H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol 300: L4-L11, 2011.
44. Thille AW, Esteban A, Fernández-Segoviano P, Rodriguez JM, Aramburu JA, Peñuelas O, Cortés-Puch I, Cardinal-Fernández P, Lorente JA, Frutos-Vivar F. Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. Am J Respir Crit Care Med 187: 761-767, 2013.
45. Vautz W, Nolte J, Bufe A, Baumbach JI, Peters M. Analyses of mouse breath with ion mobility spectrometry: A feasibility study. J Appl Physiol 108: 697-704, 2010.
46. Wang J, Wu X, Simonavicius N, Tian H, Ling L. Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J Biol Chem 281: 34457-34464, 2006.
47. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
48. Zambelli V, Di Grigoli G, Scanziani M, Valtorta S, Amigoni M, Belloli S, Messa C, Pesenti A, Fazio F, Bellani G, Moresco RM. Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury. Intensive Care Med 38: 694-701, 2012.